New firm founded to develop sleep apnoea devices
This article was originally published in Clinica
Executive Summary
Venture capital firms Sprout Group and Three Arch Partners have helped fund the establishment of a new development-stage medical device firm . Called Aspire Medical, it will focus on minimally invasive surgical implant for moderate to severe obstructive sleep apnoea (OSA), which is thought to affect some 12 million people in the US.